These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


88 related items for PubMed ID: 9033205

  • 1. Suppression of lymph node lymphoproliferation to viable Mycobacterium leprae by peripheral blood-derived monocytes.
    Birdi TJ, Desai S, Antia NH.
    Lepr Rev; 1996 Dec; 67(4):338-42. PubMed ID: 9033205
    [No Abstract] [Full Text] [Related]

  • 2. Studies on the antigenic specificity of Mycobacterium leprae. I. Demonstration of soluble antigens in leprosy nodules by immunodiffusion.
    Abe M.
    Int J Lepr Other Mycobact Dis; 1970 Dec; 38(2):113-25. PubMed ID: 4990996
    [No Abstract] [Full Text] [Related]

  • 3. Transformation of leprous lymphocytes by leprolin, tuberculin and phytohemagglutinin.
    Han SH, Weiser RS, Lin YC.
    Int J Lepr Other Mycobact Dis; 1971 Dec; 39(4):789-95. PubMed ID: 4949308
    [No Abstract] [Full Text] [Related]

  • 4. Some considerations on the origin of type 1 reactions in leprosy.
    Opromolla DV.
    Int J Lepr Other Mycobact Dis; 2005 Mar; 73(1):33-4. PubMed ID: 15898839
    [No Abstract] [Full Text] [Related]

  • 5. Lymphoproliferative responses of leprosy patients and healthy controls to nitrocellulose-bound M. leprae antigens.
    Sachdeva G, Kaur G, Bhutani LK, Bamezai RN.
    Int J Lepr Other Mycobact Dis; 1999 Jun; 67(2):133-42. PubMed ID: 10472365
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Adherence of Mycobacterium leprae to macrophage as an indicator of pathogen induced membrane changes.
    Lad SJ, Mahadevan PR.
    Indian J Med Res; 1982 Dec; 76():804-13. PubMed ID: 6762986
    [No Abstract] [Full Text] [Related]

  • 11. [Comparative characterization of the antigenic composition of M. leprae and M. lufu].
    Salamatina OS, Diachina MN, Iushchenko AA, Chernousova LN, Kalinina ON, Parshin MP.
    Probl Tuberk; 2001 Dec; (8):49-51. PubMed ID: 11767394
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Immunomodulating role of endogenous thyroid hormones in mycobacterioses].
    Balybin ES.
    Probl Tuberk; 1995 Dec; (2):37-9. PubMed ID: 7777462
    [Abstract] [Full Text] [Related]

  • 14. [Diagnosis and treatment of leprosy].
    López-Antuñano FJ.
    Salud Publica Mex; 1998 Dec; 40(1):66-75. PubMed ID: 9580503
    [No Abstract] [Full Text] [Related]

  • 15. The role of Schwann cells, T cells and Mycobacterium leprae in the immunopathogenesis of nerve damage in leprosy.
    Spierings E, De Boer T, Zulianello L, Ottenhoff TH.
    Lepr Rev; 2000 Dec; 71 Suppl():S121-9. PubMed ID: 11201869
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. T cell-monocyte contact enhances tumor necrosis factor-alpha production in response to Mycobacterium leprae.
    Sampaio EP, Oliveira RB, Warwick-Davies J, Neto RB, Griffin GE, Shattock RJ.
    J Infect Dis; 2000 Nov; 182(5):1463-72. PubMed ID: 11023469
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Progress towards development of immunoassays for detection of Mycobacterium leprae infection, employing 35kDa antigen: an update.
    Parkash O.
    Lepr Rev; 2002 Mar; 73(1):9-19. PubMed ID: 11969136
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.